Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat

Neuroscience

Volumn 117, Issue 1, 2003, Pages 43-53

  Maragos, W F ^a   Tillman, P ^a   Jones, M ^a   Bruce Keller, A J ^a   Roth, S ^a   Bell, J E ^b   Nath, A ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Acquired immunodeficiency syndrome; Dementia; Microtubule associated protein 2; Neurotoxin; Silane

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; SYNAPTOPHYSIN; TRANSACTIVATOR PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN SLICE; BRAIN TISSUE; CELL LOSS; CONTROLLED STUDY; DENTATE GYRUS; DOSE RESPONSE; ENCEPHALITIS; GLIOSIS; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NERVE CELL LESION; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; TRANSACTIVATION;

EID: 0037451775     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00713-3     Document Type: Article

References (49)

1. Bartolomei F., Pellegrino P., Dhiver C., Quilichini R., Gastaut J.A., Gastaut J.L. Epilepsy seizures in HIV infection 52 cases. Presse Med. 29:1991;2135-2138.
2. Bruce A.J., Sakhi S., Schreiber S.S., Baudry M. Development of KA and NMDA excitotoxicity in organotypic hippocampal cultures. Exp Neurol. 132:1995;209-219.
3. Chang H.C., Samaniego F., Nair B.C., Buonaguro L., Ensoli B. HIV-1 tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycan through its basic region. AIDS. 111:1997;421-1431.
4. Chen P., Mayne M., Power C., Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-α production. J Biol Chem. 272:1997;22385-22388.
5. Cheng J., Nath A., Knudsen B., Hochman S., Geiger J.D., Ma M., Magnuson D.S. Neuronal excitatory properties of human immunodeficiency virus type 1 tat protein. Neuroscience. 82:1998;97-106.
6. Conant K., Garzino-Demo A., Nath A., McArthur J.C., Halliday W., Power C., Gallo R.C., Major E.O. Induction of monocyte chemotactic protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA. 95:1998;3117-3121.
7. Davolio C., Greenamyre J.T. Selective vulnerability of the CA1 region of hippocampus to the indirect excitotoxic effects of malonic acid. Neurosci Lett. 192:1995;29-32.
8. Ensoli B., Barillari G., Salahuddin S.Z., Gallo R.C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 345:1990;84-86.
9. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type-1 Tat protein on cell growth and viral transactivation. J Virol. 67:1993;277-287.
10. Fox L., Alford M., Achim C., Mallory M., Masliah E. Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis. J Neuropathol Exp Neurol. 56:1997;360-368.
11. Fujimaura R.K., Bockstahle L.E. Polymerase chain reaction method for determining ratios of human immunodeficiency virus proviral DNA to cellular genomic DNA in brain tissues of HIV-infected patients. J Virol Methods. 55:1995;309-325.
12. Hayman M., Arbuthnott G., Harkiss G., Brace H., Filippi P., Philippon V., Thomson D., Vigne R., Wright A. Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience. 53:1993;1-6.
13. Hofman F.M., Dohadwala M.M., Wright A.D., Hinton D.R., Walker S.M. Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol. 54:1994;19-28.
14. Hudson L., Liu J., Nath A., Jones M., Raghavan R., Narayan O., Male D., Everall I. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissue. J Neurovirol. 6:2000;145-155.
15. Jones M., Olafson K., Del Bigio M.R., Peeling J., Nath A. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) Tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol. 57:1998;563-570.
16. Kerr S.J., Armati P.J., Guillemin G.J., Brew B.J. Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS. 12:1998;355-363.
17. Korbo L., West M. No loss of hippocampal neurons in AIDS patients. Acta Neuropathol. 99:2000;529-533.
18. Korematsu K., Goto S., Nagahiro S., Ushio Y. Changes of immunoreactivity for synaptophysin ('protein p38′) following a transient cerebral ischemia in the rat striatum. Brain Res. 616:1993;320-324.
19. Kruman I., Nath A., Mattson M.P. HIV protein Tat induces apoptosis by a mechanism involving mitochondrial calcium overload and caspase activation. Exp Neurol. 154:1998;276-288.
20. Luthert P.J., Montgomery M.M., Dean A.F., Cook R.W., Baskerville A., Lantos P.L. Hippocampal neuronal atrophy occurs in rhesus macaques following infection with simian immunodeficiency virus. Neuropathol Appl Neurobiol. 21:1995;529-534.
21. Ma M., Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol. 71:1997;2495-2499.
22. Magnuson D.S., Knudsen B.E., Geiger J.D., Brownstone R.M., Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol. 37:1995;373-380.
23. Malva J.O., Carvalho A.P., Carvalho C.M. Kainate receptors in hippocampal CA3 subregion Evidence for a role in regulating neurotransmitter release. Neurochem Int. 32:1998;1-6.
24. Masliah E., Ge N., Achim C.L., Hansen L.A., Wiley C.A. Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol. 51:1992;585-593.
25. Masliah E., Ge N., Morey M., DeTeresa R., Terry R.D., Wiley C.A. Cortical dendritic pathology in human deficiency virus encephalitis. Lab Invest. 66:1992;285-291.
26. Menegon A., Leoni C., Benfenati F., Valtorta F. Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum. Biochem Biophys Res Commun. 238:1997;800-805.
27. Mitchell T.W., Buckmaster P.S., Hoover E.A., Whalen L.R., Dudek F.E. Neuron loss and axon reorganization in the dentate gyrus of cats infected with the feline immunodeficiency virus. J Comp Neurol. 411:1999;563-577.
28. Nadler J.V., Perry B.W., Gentry C., Cotman C.W. Loss and reacquisition of hippocampal synapses after selective destruction of CA3-CA4 afferents with kainic acid. Brain Res. 191:1980;387-403.
29. Nath A., Geiger J.D. Neurobiological aspects of HIV infections Neurotoxic mechanisms. Prog Neurobiol. 54:1998;19-33.
30. Nath A, Geiger J, Mattson M, Magnuson D, Jones M, Berger J (1998) Role of viral proteins in neuropathogenesis of HIV infection with emphasis on Tat. (www.sciencemag.org/NAIDS) NeuroAIDS 1, Oct.
31. Nath A., Conant K., Chen P., Scott C., Major E.O. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem. 274:1999;17098-17102.
32. New D., Ma M., Epstein L.G., Nath A., Gelbard H.A. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol. 3:1997;168-173.
33. New D.R., Maggirwar S.B., Epstein L.G., Dewhurst S., Gelbard H.A. HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J Biol Chem. 273:1998;17852-17858.
34. Pang Z., Umberger G.H., Geddes J.W. Neuronal loss and cytoskeletal disruption following intrahippocampal administration of the metabolic inhibitor malonate Lack of protection by MK-801. J Neurochem. 66:1996;474-484.
35. Persidsky Y., Buttini M., Limoges J., Bock P., Gendelman H.E. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J Neurovirol. 3:1997;401-416.
36. Petito C.K., Roberts B., Cantando J.D., Rabinstein A., Duncan R. Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS. J Neuropathol Exp Neurol. 60:2001;377-385.
37. Philippon V., Vellutini C., Gambarelli D., Harkiss G., Arbuthnolt G., Metzger D., Roubin R., Filippi P. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain Involvement of cytokines. Virol. 205:1994;519-529.
38. Reyes E., Mohar A., Mallory M., Miller A., Masliah E. Hippocampal involvement associated with human immunodeficiency virus encephalitis in Mexico. Arch Pathol Lab Med. 118:1994;1130-1134.
39. Runden E., Seglen P.O., Haug F.M., Ottersen O.P., Wieloch T., Shamloo M., Laake J.H. Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures Evidence for a MAP kinase-dependent mechanism. J Neurosci. 18:1998;7296-7305.
40. Shi B., Raina J., Lorenzo A., Busciglio J., Gabuzda D. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha Potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol. 4:1998;281-290.
41. Smith D.G., Guillemin G.J., Pemberton L., Kerr S., Nath A., Smythe G., Brew B.J. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J Neurovirol. 7:2001;56-60.
42. Spargo E., Everall I.P., Lantos P.L. Neuronal loss in hippocampus in Huntington's disease A comparison with HIV infection. J Neurol Neurosurg Psychiatry. 56:1993;487-491.
43. Tardieu M., Hery C., Peudenier S., Boespflug O., Montagnier L. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol. 32:1992;11-17.
44. Valle L.D., Croul S., Morgello S., Amini S., Rappaport J., Khalili K. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol. 6:2000;221-228.
45. Weiss J.M., Nath A., Major E.O., Berman J.W. HIV-Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain-barrier and upregulates CCR5 expression on human monocytes. J Immunol. 163:1999;2953-2959.
46. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:1995;497-500.
47. Woolf N.J. A structural basis for memory storage in mammals. Prog Neurobiol. 55:1998;59-77.
48. Wong M.C., Suite N., Labar D.R. Seizures in human immunodeficiency virus infection. Arch Neurol. 47:1990;640-642.
49. Zaczek R., Simonton S., Coyle J.T. Local and distant neuronal degeneration following intrastriatal injection of kainic acid. J Neuropathol Exp Neurol. 39:1980;245-264.